Cadre Holdings, Inc. Increase (Decrease) in Accounts Payable and Other Operating Liabilities
Cadre Holdings, Inc. (CDRE) reported Increase (Decrease) in Accounts Payable and Other Operating Liabilities of $24.74 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities · last filed 2026-08-05
- Cadre Holdings, Inc. increase (decrease) in accounts payable and other operating liabilities for the quarter ending 2026-06-30 was $11.21M.
- Cadre Holdings, Inc. increase (decrease) in accounts payable and other operating liabilities for the quarter ending 2026-03-31 was $13.54M.
- Cadre Holdings, Inc. increase (decrease) in accounts payable and other operating liabilities for the quarter ending 2025-12-31 was $535.00K, a 90.22% decline year-over-year.
- Cadre Holdings, Inc. increase (decrease) in accounts payable and other operating liabilities for the quarter ending 2025-09-30 was -$1.09M, a 221.18% decline year-over-year.
- Cadre Holdings, Inc. increase (decrease) in accounts payable and other operating liabilities for fiscal 2025 was -$16.41M.
- Cadre Holdings, Inc. increase (decrease) in accounts payable and other operating liabilities for fiscal 2024 was -$15.62M, a 211.33% decline from fiscal 2023.
- Cadre Holdings, Inc. increase (decrease) in accounts payable and other operating liabilities for fiscal 2023 was $14.03M, a 155.49% increase from fiscal 2022.
- Cadre Holdings, Inc. increase (decrease) in accounts payable and other operating liabilities for fiscal 2022 was $5.49M, a 101.95% increase from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Payable and Other Operating Liabilities 3 month | Increase (Decrease) in Accounts Payable and Other Operating Liabilities 6 month | Increase (Decrease) in Accounts Payable and Other Operating Liabilities 9 month | Increase (Decrease) in Accounts Payable and Other Operating Liabilities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $11.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $24.74M 10-Q · filed 2026-08-05 | $25.28M derived: sum of 3 quarters · filed 2026-08-05 | $24.19M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $13.54M 10-Q · filed 2026-05-11 | $14.07M derived: sum of 2 quarters · filed 2026-05-11 | $12.98M derived: sum of 3 quarters · filed 2026-05-11 | -$1.70M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $535.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | -$558.00K derived: sum of 2 quarters · filed 2026-03-10 | -$15.24M derived: sum of 3 quarters · filed 2026-08-05 | -$16.41M 10-K · filed 2026-03-10 |
| 2025-09-30 | -$1.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$15.77M derived: sum of 2 quarters · filed 2026-08-05 | -$16.94M 10-Q · filed 2025-11-04 | -$11.47M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | -$14.68M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$15.85M 10-Q · filed 2026-08-05 | -$10.38M derived: sum of 3 quarters · filed 2026-08-05 | -$9.47M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | -$1.17M 10-Q · filed 2026-05-11 | $4.30M derived: sum of 2 quarters · filed 2026-05-11 | $5.21M derived: sum of 3 quarters · filed 2026-05-11 | $4.93M derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | $5.47M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $6.37M derived: sum of 2 quarters · filed 2026-03-10 | $6.10M derived: sum of 3 quarters · filed 2026-03-10 | -$15.62M 10-K · filed 2026-03-10 |
| 2024-09-30 | $902.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $627.00K derived: sum of 2 quarters · filed 2025-11-04 | -$21.10M 10-Q · filed 2025-11-04 | -$15.69M derived: sum of 4 quarters · filed 2026-03-10 |
| 2024-06-30 | -$275.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | -$22.00M 10-Q · filed 2025-08-05 | -$16.59M derived: sum of 3 quarters · filed 2026-03-10 | -$6.99M derived: sum of 4 quarters · filed 2026-03-10 |
| 2024-03-31 | -$21.72M 10-Q · filed 2025-05-06 | -$16.31M derived: sum of 2 quarters · filed 2026-03-10 | -$6.72M derived: sum of 3 quarters · filed 2026-03-10 | -$3.74M derived: sum of 4 quarters · filed 2026-03-10 |
| 2023-12-31 | $5.41M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $15.01M derived: sum of 2 quarters · filed 2026-03-10 | $17.98M derived: sum of 3 quarters · filed 2026-03-10 | $14.03M 10-K · filed 2026-03-10 |
| 2023-09-30 | $9.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $12.57M derived: sum of 2 quarters · filed 2024-11-06 | $8.62M 10-Q · filed 2024-11-06 | $18.78M derived: sum of 4 quarters · filed 2025-03-11 |
| 2023-06-30 | $2.98M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | -$971.00K 10-Q · filed 2024-08-09 | $9.18M derived: sum of 3 quarters · filed 2025-03-11 | $4.87M derived: sum of 4 quarters · filed 2025-03-11 |
| 2023-03-31 | -$3.95M 10-Q · filed 2024-05-08 | $6.21M derived: sum of 2 quarters · filed 2025-03-11 | $1.89M derived: sum of 3 quarters · filed 2025-03-11 | $1.56M derived: sum of 4 quarters · filed 2025-03-11 |
| 2022-12-31 | $10.15M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | $5.84M derived: sum of 2 quarters · filed 2025-03-11 | $5.51M derived: sum of 3 quarters · filed 2025-03-11 | $5.49M 10-K · filed 2025-03-11 |
| 2022-09-30 | -$4.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | -$4.64M derived: sum of 2 quarters · filed 2023-11-08 | -$4.66M 10-Q · filed 2023-11-08 | -$8.52M derived: sum of 4 quarters · filed 2024-03-12 |
| 2022-06-30 | -$327.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | -$345.00K 10-Q · filed 2023-08-08 | -$4.21M derived: sum of 3 quarters · filed 2024-03-12 | -$6.83M derived: sum of 4 quarters · filed 2024-03-12 |
| 2022-03-31 | -$18.00K 10-Q · filed 2023-05-09 | -$3.88M derived: sum of 2 quarters · filed 2024-03-12 | -$6.51M derived: sum of 3 quarters · filed 2024-03-12 | -$7.98M derived: sum of 4 quarters · filed 2024-03-12 |
| 2021-12-31 | -$3.86M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | -$6.49M derived: sum of 2 quarters · filed 2024-03-12 | -$7.96M derived: sum of 3 quarters · filed 2024-03-12 | $2.72M 10-K · filed 2024-03-12 |
| 2021-09-30 | -$2.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$4.10M derived: sum of 2 quarters · filed 2022-11-10 | $6.58M 10-Q · filed 2022-11-10 | $5.29M derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | -$1.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $9.21M 10-Q · filed 2022-08-11 | $7.92M derived: sum of 3 quarters · filed 2022-08-11 | |
| 2021-03-31 | $10.68M 10-Q · filed 2022-05-16 | $9.39M derived: sum of 2 quarters · filed 2022-05-16 | ||
| 2020-12-31 | -$1.29M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $2.12M 10-K · filed 2022-03-11 | ||
| 2020-09-30 | $3.41M 10-Q · filed 2021-12-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B | |
| NutriBand Inc. (NTRB) | United States | $0.109B | |
| LAKELAND INDUSTRIES INC (LAKE) | United States | $0.104B | -4.21 |
| Safe Pro Group Inc. (SPAI) | United States | $0.090B | |
| MYOMO, INC. (MYO) | United States | $0.065B | -2.85 |